Temps réel estimé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
0,675 USD | -1,03% | -19,26% | -11,83% |
Métier
Nombre d'employés: 9
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Robert Bitterman
CEO | Chief Executive Officer | 73 | 19/06/12 |
Caitlin Kontulis
DFI | Director of Finance/CFO | - | - |
James Cardia
CTO | Chief Tech/Sci/R&D Officer | - | 15/09/17 |
Linda M. Mahoney
PRN | Corporate Officer/Principal | - | 10/11/22 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Robert Bitterman
CEO | Chief Executive Officer | 73 | 19/06/12 |
Director/Board Member | 73 | 02/05/22 | |
Curtis Lockshin
BRD | Director/Board Member | 64 | 18/04/13 |
Jonathan Freeman
BRD | Director/Board Member | 56 | 07/06/17 |
Robert Ferrara
BRD | Director/Board Member | 73 | 01/10/19 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 4 591 700 | 4 564 638 ( 99,41 %) | 0 | 99,41 % |
Coordonnées société
Phio Pharmaceuticals Corp.
11 Apex Drive Suite 300A PMB 2006
01752, Marlborough
+508 767 3861
http://www.phiopharma.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-11,83% | 3,13 M | |
+2,17% | 42,75 Md | |
+47,70% | 41,61 Md | |
+12,21% | 41,34 Md | |
-8,83% | 26,59 Md | |
+6,43% | 25,49 Md | |
-22,92% | 18,12 Md | |
+30,28% | 12,24 Md | |
-2,10% | 11,76 Md | |
+8,99% | 11 Md |
- Bourse
- Actions
- Action PHIO
- Société Phio Pharmaceuticals Corp.